|Actemra subcutaneous injection
|Actemra is used to treat adults with moderate to severe active rheumatoid arthritis who have not had a good response to one or more Disease-Modifying Anti-Rheumatic Drugs (DMARDs); patients age 2 and older with active polyarticular juvenile idiopathic arthritis; and patients age 2 and older with active systemic juvenile idiopathic arthritis.
|Capecitabine is an oral chemotherapy agent used to treat adjuvant colon cancer, metastatic colorectal cancer, and metastatic breast cancer.
||Myalept is approved as replacement therapy to treat the complications of leptin deficiency in patients with congenital or acquired generalized lipodystrophy.
||Orenitram is used to reduce symptoms of certain kinds of pulmonary arterial hypertension (WHO Group 1) and improve exercise capacity.
[coagulation Factor IX (recombinant)]
|Rixubis is used to prevent and control bleeding episodes in adults with hemophilia B.
|Tretten [coagulation Factor VIII A-Subunit (recombinant)]
||Tretten is used to prevent bleeds in people with congenital factor XIII A-subunit deficiency.
|Vimizim is an enzyme replacement therapy for people with Mucopolysaccharidosis type IVA (MPS IVA; Morquio A syndrome)